UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Investing in Women Trainees: Building a Women in Medicine Group at an Academic Institution

Journal of medical Internet research, 2023-05, Vol.25 (1), p.e47783-e47783

2023

Volltextzugriff (PDF)

Distinctive Characteristics of Non-small Cell Lung Cancer (NSCLC) in the Young: A Surveillance, Epidemiology, and End Results (SEER) Analysis

Journal of thoracic oncology, 2010-01, Vol.5 (1), p.23-28

2010

Volltextzugriff (PDF)

Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis

Journal of thoracic oncology, 2007-09, Vol.2 (9), p.845-853

2007

Volltextzugriff (PDF)

Barriers to Enrollment in Non-small Cell Lung Cancer Therapeutic Clinical Trials

Journal of thoracic oncology, 2011-01, Vol.6 (1), p.98-102

2011

Volltextzugriff (PDF)

Delayed nausea and vomiting from carboplatin doublet chemotherapy

Acta oncologica, 2016-06, Vol.55 (6), p.700-704

2016

Volltextzugriff (PDF)

Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer

Cancer epidemiology, biomarkers & prevention, 2024-08, Vol.33 (8), p.1091-1097

2024

Volltextzugriff (PDF)

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base

Journal of clinical oncology, 2015-03, Vol.33 (8), p.870-876

2015

Volltextzugriff (PDF)

Pulsatile Erlotinib in EGFR-Positive Non-Small Cell Lung Cancer Patients with Leptomeningeal and Brain Metastases: Review of the Literature

Clinical lung cancer, 2017-07, Vol.18 (4), p.354-363

2017

Volltextzugriff (PDF)

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2022-07, Vol.113 (4), p.742-748

2022

Volltextzugriff (PDF)

Prevalence of Women in Medicine Programs at University-Based Internal Medicine Residency Programs

Southern medical journal (Birmingham, Ala.), 2024-02, Vol.117 (2), p.98-101

2024

Volltextzugriff (PDF)

Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR -Mutant Non–Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

JAMA oncology, 2019-10, Vol.5 (10), p.1448

2019

Volltextzugriff (PDF)

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2184-2192

2017

Volltextzugriff (PDF)

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

Journal of thoracic oncology, 2011-10, Vol.6 (10), p.1757-1760

2011

Volltextzugriff (PDF)

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies

European journal of cancer (1990), 2021-09, Vol.154, p.102-110

2021

Volltextzugriff (PDF)

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2022-04, Vol.89 (4), p.487-497

2022

Volltextzugriff (PDF)

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Journal of thoracic oncology, 2017-05, Vol.12 (5), p.843-849

2017

Volltextzugriff (PDF)

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations

Journal of thoracic disease, 2021-07, Vol.13 (7), p.4054-4062

2021

Volltextzugriff (PDF)

Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial

Urologic oncology, 2011-11, Vol.29 (6), p.608-613

2011

Volltextzugriff (PDF)

A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer

Chemotherapy (Basel), 2016-01, Vol.61 (3), p.144-147

2016

Volltextzugriff (PDF)

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy

Clinical lung cancer, 2020-07, Vol.21 (4), p.357-364.e7

2020

Volltextzugriff (PDF)

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Lung cancer (Amsterdam, Netherlands), 2017-09, Vol.111, p.108-115

2017

Volltextzugriff (PDF)

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)

Investigational new drugs, 2017-10, Vol.35 (5), p.608-615

2017

Volltextzugriff (PDF)

The Effect of FDG-PET on the Stage Distribution of Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-02, Vol.3 (2), p.135-139

2008

Volltextzugriff (PDF)

Radiotherapy

Journal of thoracic oncology, 2010-12, Vol.5 (12), p.S476-S477

2010

Volltextzugriff (PDF)

Lung Cancer in Older Adults

Current geriatrics reports, 2014-09, Vol.3 (3), p.166-174

2014

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(39)
Buchkapitel
(2)

Sprache

Englisch
(39)
Französisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Investing in Women Trainees: Building a Women in Medicine Group at an Academic Institution

Distinctive Characteristics of Non-small Cell Lung Cancer (NSCLC) in the Young: A Surveillance, Epidemiology, and End Results (SEER) Analysis

Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis

Barriers to Enrollment in Non-small Cell Lung Cancer Therapeutic Clinical Trials

Delayed nausea and vomiting from carboplatin doublet chemotherapy

Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base

Pulsatile Erlotinib in EGFR-Positive Non-Small Cell Lung Cancer Patients with Leptomeningeal and Brain Metastases: Review of the Literature

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer

Prevalence of Women in Medicine Programs at University-Based Internal Medicine Residency Programs

Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR -Mutant Non–Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations

Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial

A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)

The Effect of FDG-PET on the Stage Distribution of Non-small Cell Lung Cancer

Radiotherapy

Lung Cancer in Older Adults

Suchergebnisse filtern